FDA Inspection 1107250 — SEAGEN INC.
The FDA completed an inspection of SEAGEN INC. on October 4, 2019 in Bothell, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 4, 2019
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Bothell, WA (United States)
Additional Details
Sponsor, Contract Research Organization